Exclusion Criteria:~* Patients with clinically significant cardiac, hepatic or renal impairment~* Patient have
a dementia not of the Alzheimer's type etc (According to the protocol)~* Patients who are taking any drug other
than donepezil or rivastigmine transdermal system for Alzheimer's disease, including olal rivastigmine
(ExelonÂ®), galantamine (RazadyneÂ®)
